The Brain Buzz
BrainFx Sponsors Rehab Tech Summit 2022
February 3, 2022 BrainFx is proud to be a platinum sponsor of Rehab Tech Summit 2022! This year, along with another platinum sponsor NeuroCatch, we’re kicking off this virtual event to celebrate innovation in the neuro-rehab space on March 4-5 opening weekend. Get...
Highmark Interactive Inc. Begins trading on the TSX Venture Exchange
TORONTO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Highmark Interactive Inc. (“Highmark” or the “Company”) is pleased to announce approval for trading on the TSX Venture Exchange (“TSXV”) under the symbol HMRK on November 17th, 2021. The listing follows the closing of the...
Highmark Interactive Announces Collaboration with Mayo Clinic to Assess Impact of “Long COVID” on Cognitive Function
TORONTO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- BrainFx, a wholly owned subsidiary of Highmark Interactive, today announces its collaboration with Mayo Clinic to assess the impact of "Long COVID" or "Post-COVID-19 Syndrome" on cognitive function. Long COVID, according to...
BrainFx acquired by Highmark Innovations Inc.
TORONTO, ON, June 8, 2021 – BrainFx is pleased to announce today our acquisition by Highmark Innovations (operating as ‘Highmark Interactive’). Highmark is a digital health leader in brain and mental wellness, along with providing a new hybrid model for the delivery...
BrainFx joins Mayo Clinic and Arizona State University at Prestigious MedTech Accelerator
BrainFx is honored to join the Mayo Clinic and Arizona State University in the second cohort of their prestigious MedTech Accelerator which hand-selects a few leading startup health companies to support across the market. The MedTech Accelerator is...
Think Research Expands Telemedicine Software to Offer Remote Cognitive Assessment Tool for Virtual Mental Health Care
TORONTO, March 10, 2021 — Think Research Corporation (“Think“) (TSXV: THNK), a company focused on transforming healthcare through integrated digital health software solutions, today announced it is further expanding its telemedicine software offering for mental...
NeuroCatch Inc. Partners with BrainFx on Neuro Health Innovation
January 21, 2021 An exciting new partnership between BrainFx and NeuroCatch (NCI)! NeuroCatch Inc. (NCI) in Surrey, British Columbia and BrainFx in Pickering, Ontario will be working together to share their initiatives, best practices, and...
BrainFx and Maple Announce Partnership To Expand Canadians’ Access To Cognitive Functional Assessments For Neurofunctional Health
October 30, 2020 -- BrainFx, a leading digital cognitive functional assessment platform, and Maple, Canada's leading virtual care provider, have entered into a partnership to expand Canadians' access to cognitive functional assessments for neurofunctional health. The...
Helius Medical Technologies (Canada) Joins Forces With BrainFx To Create Educational Awareness On Innovative Treatment And Assessments In Brain Health
October 28, 2020 -- Helius Medical Technologies (Canada), subsidiary of Helius Medical Technologies, Inc, a neurotech company focused on neurological wellness and BrainFx, a leading digital neurofunctional assessment platform are teaming up to educate...
The Implications of Missing Mild Cognitive Impairment
Introduction Brain disorders can impact us at any age. In early childhood it could be anything from congenital to acquired conditions, and as we grow older it could be injury, chronic disease, mental health, strokes, heart attacks, and even the start of cognitive...
Our latest research
Working with the Mayo Clinic to understand Long-COVID
This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researches to better understand and address the impacts of this new and emerging phenomena.
Interested in working with us?
Get in touch with us below to learn more
Let's make the INVISIBLE effects of brain disorders VISIBLE, together.
Our Portals
Copyright © 2022 - BrainFx. All rights reserved.
Important Information: BrainFx Assessments only provide information about neurofunctional performance. Assessment results detail the patient/client's performance on assessment activities completed and only assist the health care team in identifying potential areas of strength or challenge as related to function. Assessments DO NOT provide any diagnosis or treatment recommendations. BrainFx Assessments are only permitted to be delivered by trained clinicians. Assessment reports are not stand-alone and require the interpretation of a health professional within their scope of practice and in the context of all information that they have gathered about their patient/client. In Canada, BrainFx Assessments are cleared by Health Canada as a Class 1 Software as a Medical Device. BrainFx Assessments and the statements made on this website have not been evaluated by any other regulatory bodies. Assessments are not intended to diagnose, treat, cure, or prevent any disease. Information provided by BrainFx is not a substitute for face-to-face consultation with your health care professional and should not be construed as individual medical advice.